drugset / Trial / NCT01909466

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

NCT01909466

RandomizedParallel-groupOpen-labelTreatment

Summary

To determine the safety and tolerability of multiple-dose administrations of aripiprazole intramuscular (IM) depot in the deltoid muscle in adult subjects with schizophrenia

Timeline

Start
2013-07
Primary completion
2014-03
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 400 mg Intramuscular

Indications